Keyphrases
In Cancer
100%
Cancer Immunotherapy
100%
Dendritic Cells
100%
Myeloid Dendritic Cells
100%
Th9 Cells
100%
Interleukin-3
27%
Interleukin-9
18%
Tumor Immunity
9%
Signaling Pathway
9%
T Cell Response
9%
Bone Marrow
9%
C57BL
9%
Cell Survival
9%
Cell Culture
9%
Bcl-xL
9%
P38 Signaling Pathway
9%
Tumor-bearing Mice
9%
Long-term Survival
9%
Human Cancer
9%
Anti-apoptotic Proteins
9%
Immune Cells
9%
OT-II
9%
Mechanistic Studies
9%
Melanoma B16
9%
Prolonged Survival
9%
Cell-derived
9%
Anti-tumor Response
9%
Survival Time
9%
Professional Antigen-presenting Cells
9%
ERK Pathway
9%
Cellular Immunotherapy
9%
Apoptotic Cells
9%
Dendritic Cell Vaccine
9%
Mouse Dendritic Cells
9%
Transwell
9%
T Helper 9 Cells
9%
STAT5 Signaling
9%
Medicine and Dentistry
Cancer Immunotherapy
100%
Dendritic Cell
100%
Myeloid Dendritic Cell
100%
Th9 Cell
100%
Interleukin 3
25%
Neoplasm
16%
Interleukin 9
16%
Cancer
8%
Immunotherapy
8%
In Vitro
8%
Tumor Immunity
8%
T-Cell Response
8%
Immune Response
8%
Antigen Presenting Cell
8%
Cell Signaling Pathway
8%
C57BL/6
8%
Melanoma B16
8%
Cell Survival
8%
Antiapoptotic
8%
Survival Time
8%
Protein Bcl Xl
8%
Dendritic Cell Vaccine
8%
Immunology and Microbiology
Dendritic Cell
100%
Myeloid Dendritic Cell
100%
Cancer Immunotherapy
100%
Th9 Cell
100%
Interleukin 3
25%
Interleukin 9
16%
Immune Response
8%
T Cell
8%
Immunotherapy
8%
Cell Survival
8%
Antigen-Presenting Cell
8%
C57BL 6 Mouse
8%
STAT5
8%
Survival Time
8%
Dendritic Cell Vaccine
8%
Tumor Immunity
8%